ID   ROBO1_HUMAN             Reviewed;        1651 AA.
AC   Q9Y6N7; B2RXI1; D3DU36; E9PD49; Q1RMC7; Q7Z300; Q9BUS7;
DT   21-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   22-JUL-2015, entry version 139.
DE   RecName: Full=Roundabout homolog 1;
DE   AltName: Full=Deleted in U twenty twenty;
DE   AltName: Full=H-Robo-1;
DE   Flags: Precursor;
GN   Name=ROBO1; Synonyms=DUTT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9458045; DOI=10.1016/S0092-8674(00)80915-0;
RA   Kidd T., Brose K., Mitchell K.J., Fetter R.D., Tessier-Lavigne M.,
RA   Goodman C.S., Tear G.;
RT   "Roundabout controls axon crossing of the CNS midline and defines a
RT   novel subfamily of evolutionarily conserved guidance receptors.";
RL   Cell 92:205-215(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 5 AND 6), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1158-1651 (ISOFORMS
RP   1/2/3/4).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 366-1651 (ISOFORM 2).
RC   TISSUE=Uterine endothelium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH SLIT2.
RC   TISSUE=Fetal brain;
RX   PubMed=10102268; DOI=10.1016/S0092-8674(00)80590-5;
RA   Brose K., Bland K.S., Wang K.H., Arnott D., Henzel W., Goodman C.S.,
RA   Tessier-Lavigne M., Kidd T.;
RT   "Slit proteins bind Robo receptors and have an evolutionarily
RT   conserved role in repulsive axon guidance.";
RL   Cell 96:795-806(1999).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=9608531; DOI=10.1006/mcne.1998.0672;
RA   Sundaresan V., Roberts I., Bateman A., Bankier A., Sheppard M.,
RA   Hobbs C., Xiong J., Minna J., Latif F., Lerman M., Rabbitts P.;
RT   "The DUTT1 gene, a novel NCAM family member is expressed in developing
RT   murine neural tissues and has an unusually broad pattern of
RT   expression.";
RL   Mol. Cell. Neurosci. 11:29-35(1998).
RN   [8]
RP   MAPPING, AND IDENTIFICATION (ISOFORM 3).
RX   PubMed=9796701; DOI=10.1038/sj.onc.1202103;
RA   Sundaresan V., Chung G., Heppell-Parton A., Xiong J., Grundy C.,
RA   Roberts I., James L., Cahn A., Bench A., Douglas J., Minna J.,
RA   Sekido Y., Lerman M., Latif F., Bergh J., Li H., Lowe N., Ogilvie D.,
RA   Rabbitts P.;
RT   "Homozygous deletions at 3p12 in breast and lung cancer.";
RL   Oncogene 17:1723-1729(1998).
RN   [9]
RP   PHOSPHORYLATION AT TYR-1038; TYR-1073 AND TYR-1114.
RX   PubMed=10892742; DOI=10.1016/S0092-8674(00)80883-1;
RA   Bashaw G.J., Kidd T., Murray D., Pawson T., Goodman C.S.;
RT   "Repulsive axon guidance: Abelson and Enabled play opposing roles
RT   downstream of the roundabout receptor.";
RL   Cell 101:703-715(2000).
RN   [10]
RP   INTERACTION WITH SLIT2.
RX   PubMed=11404413;
RA   Nguyen-Ba-Charvet K.T., Brose K., Ma L., Wang K.H., Marillat V.,
RA   Sotelo C., Tessier-Lavigne M., Chedotal A.;
RT   "Diversity and specificity of actions of Slit2 proteolytic fragments
RT   in axon guidance.";
RL   J. Neurosci. 21:4281-4289(2001).
RN   [11]
RP   PROMOTER HYPERMETHYLATION, AND VARIANTS ASN-1055 AND ASP-1533.
RX   PubMed=12082532; DOI=10.1038/sj.onc.1205421;
RA   Dallol A., Forgacs E., Martinez A., Sekido Y., Walker R., Kishida T.,
RA   Rabbitts P., Maher E.R., Minna J.D., Latif F.;
RT   "Tumour specific promoter region methylation of the human homologue of
RT   the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers.";
RL   Oncogene 21:3020-3028(2002).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-940; SER-1055; THR-1240
RP   AND SER-1297, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-940, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   SUBUNIT.
RX   PubMed=24673457; DOI=10.1042/BJ20140190;
RA   Zakrys L., Ward R.J., Pediani J.D., Godin A.G., Graham G.J.,
RA   Milligan G.;
RT   "Roundabout 1 exists predominantly as a basal dimeric complex and this
RT   is unaffected by binding of the ligand Slit2.";
RL   Biochem. J. 461:61-73(2014).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 61-166 IN COMPLEX WITH SLIT2,
RP   AND DISULFIDE BOND.
RX   PubMed=17848514; DOI=10.1073/pnas.0705310104;
RA   Morlot C., Thielens N.M., Ravelli R.B., Hemrika W., Romijn R.A.,
RA   Gros P., Cusack S., McCarthy A.A.;
RT   "Structural insights into the Slit-Robo complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:14923-14928(2007).
RN   [18]
RP   STRUCTURE BY NMR OF 454-564.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the fifth Ig-like domain from human roundabout
RT   homolog 1.";
RL   Submitted (OCT-2007) to the PDB data bank.
CC   -!- FUNCTION: Receptor for SLIT1 and SLIT2 which are thought to act as
CC       molecular guidance cue in cellular migration, including axonal
CC       navigation at the ventral midline of the neural tube and
CC       projection of axons to different regions during neuronal
CC       development. In axon growth cones, the silencing of the attractive
CC       effect of NTN1 by SLIT2 may require the formation of a ROBO1-DCC
CC       complex. May be required for lung development.
CC       {ECO:0000269|PubMed:10102268}.
CC   -!- SUBUNIT: Homodimer. Dimerization is mediated by the extracellular
CC       domain and is independent of SLIT liganding. Interacts with SLIT1
CC       and SLIT2. {ECO:0000269|PubMed:10102268,
CC       ECO:0000269|PubMed:11404413, ECO:0000269|PubMed:17848514,
CC       ECO:0000269|PubMed:24673457}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q9Y6N7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y6N7-2; Sequence=VSP_010646;
CC         Note=Incomplete.;
CC       Name=3;
CC         IsoId=Q9Y6N7-3; Sequence=VSP_010643, VSP_010644, VSP_010645;
CC       Name=4;
CC         IsoId=Q9Y6N7-4; Sequence=VSP_010643, VSP_010644;
CC       Name=5;
CC         IsoId=Q9Y6N7-5; Sequence=VSP_043881, VSP_010645, VSP_043882;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=Q9Y6N7-6; Sequence=VSP_043881, VSP_010645, VSP_043882,
CC                                  VSP_046084;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with exception of kidney.
CC       {ECO:0000269|PubMed:9608531}.
CC   -!- PTM: Ubiquitinated. May be deubiquitinated by USP33 (By
CC       similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: Maps within a region of overlapping homozygous
CC       deletions characterized in both small cell lung cancer cell lines
CC       (SCLC) and in a breast cancer cell line. The promoter region of
CC       ROBO1 shows complete hypermethylation of CpG sites in the BT-20
CC       breast tumor cell lines, some primary invasive breast carcinomasa
CC       and some primary clear cell renal cell carcinomas (CC-RCC).
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. ROBO
CC       family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 3 fibronectin type-III domains.
CC       {ECO:0000255|PROSITE-ProRule:PRU00316}.
CC   -!- SIMILARITY: Contains 5 Ig-like C2-type (immunoglobulin-like)
CC       domains. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ROBO1ID42140ch3p12.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF040990; AAC39575.1; -; mRNA.
DR   EMBL; Z95705; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016946; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC055731; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC106718; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC106720; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC108719; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117461; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117479; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC119035; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC123565; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC125624; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC125766; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC125815; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC131008; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471110; EAW68884.1; -; Genomic_DNA.
DR   EMBL; CH471110; EAW68885.1; -; Genomic_DNA.
DR   EMBL; BC001969; AAH01969.1; -; mRNA.
DR   EMBL; BC115022; AAI15023.1; -; mRNA.
DR   EMBL; BC157861; AAI57862.1; -; mRNA.
DR   EMBL; BC171855; AAI71855.1; -; mRNA.
DR   EMBL; BX538319; CAD98093.1; -; mRNA.
DR   CCDS; CCDS46872.2; -. [Q9Y6N7-5]
DR   CCDS; CCDS54610.1; -. [Q9Y6N7-6]
DR   CCDS; CCDS54611.1; -. [Q9Y6N7-1]
DR   RefSeq; NP_001139317.1; NM_001145845.1. [Q9Y6N7-6]
DR   RefSeq; NP_002932.1; NM_002941.3. [Q9Y6N7-1]
DR   RefSeq; NP_598334.2; NM_133631.3. [Q9Y6N7-5]
DR   RefSeq; XP_006713340.1; XM_006713277.2. [Q9Y6N7-3]
DR   UniGene; Hs.744218; -.
DR   PDB; 2EO9; NMR; -; A=454-564.
DR   PDB; 2V9Q; X-ray; 2.50 A; A=61-266.
DR   PDB; 2V9R; X-ray; 2.00 A; A=61-266.
DR   PDB; 2V9T; X-ray; 1.70 A; A=61-166.
DR   PDB; 3WIH; X-ray; 1.70 A; A/B=777-873.
DR   PDB; 4HLJ; X-ray; 1.80 A; A=660-897.
DR   PDBsum; 2EO9; -.
DR   PDBsum; 2V9Q; -.
DR   PDBsum; 2V9R; -.
DR   PDBsum; 2V9T; -.
DR   PDBsum; 3WIH; -.
DR   PDBsum; 4HLJ; -.
DR   ProteinModelPortal; Q9Y6N7; -.
DR   SMR; Q9Y6N7; 61-266, 454-564, 660-885.
DR   BioGrid; 112018; 5.
DR   DIP; DIP-33034N; -.
DR   IntAct; Q9Y6N7; 4.
DR   MINT; MINT-1392694; -.
DR   STRING; 9606.ENSP00000420321; -.
DR   PhosphoSite; Q9Y6N7; -.
DR   BioMuta; ROBO1; -.
DR   DMDM; 49036500; -.
DR   MaxQB; Q9Y6N7; -.
DR   PaxDb; Q9Y6N7; -.
DR   PRIDE; Q9Y6N7; -.
DR   Ensembl; ENST00000464233; ENSP00000420321; ENSG00000169855.
DR   Ensembl; ENST00000467549; ENSP00000417992; ENSG00000169855. [Q9Y6N7-6]
DR   Ensembl; ENST00000495273; ENSP00000420637; ENSG00000169855. [Q9Y6N7-5]
DR   GeneID; 6091; -.
DR   KEGG; hsa:6091; -.
DR   UCSC; uc003dqb.2; human. [Q9Y6N7-4]
DR   UCSC; uc003dqd.2; human. [Q9Y6N7-5]
DR   UCSC; uc003dqe.2; human. [Q9Y6N7-1]
DR   CTD; 6091; -.
DR   GeneCards; GC03M078729; -.
DR   HGNC; HGNC:10249; ROBO1.
DR   HPA; CAB013524; -.
DR   HPA; HPA052968; -.
DR   MIM; 602430; gene.
DR   neXtProt; NX_Q9Y6N7; -.
DR   PharmGKB; PA34620; -.
DR   eggNOG; NOG238978; -.
DR   GeneTree; ENSGT00760000118840; -.
DR   HOGENOM; HOG000010267; -.
DR   HOVERGEN; HBG073476; -.
DR   InParanoid; Q9Y6N7; -.
DR   KO; K06753; -.
DR   OMA; QCPRPTS; -.
DR   OrthoDB; EOG7KWSGP; -.
DR   PhylomeDB; Q9Y6N7; -.
DR   TreeFam; TF351053; -.
DR   Reactome; REACT_19226; Activation of Rac.
DR   Reactome; REACT_19230; Role of Abl in Robo-Slit signaling.
DR   Reactome; REACT_19342; Inactivation of Cdc42 and Rac.
DR   Reactome; REACT_19351; Signaling by Robo receptor.
DR   Reactome; REACT_19376; Regulation of Commissural axon pathfinding by Slit and Robo.
DR   Reactome; REACT_22237; Netrin-1 signaling.
DR   ChiTaRS; ROBO1; human.
DR   EvolutionaryTrace; Q9Y6N7; -.
DR   GeneWiki; ROBO1; -.
DR   GenomeRNAi; 6091; -.
DR   NextBio; 23685; -.
DR   PRO; PR:Q9Y6N7; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; Q9Y6N7; -.
DR   CleanEx; HS_ROBO1; -.
DR   ExpressionAtlas; Q9Y6N7; baseline and differential.
DR   Genevisible; Q9Y6N7; HS.
DR   GO; GO:0030673; C:axolemma; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008046; F:axon guidance receptor activity; TAS:ProtInc.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0030275; F:LRR domain binding; IPI:UniProtKB.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; TAS:Reactome.
DR   GO; GO:0016199; P:axon midline choice point recognition; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0002042; P:cell migration involved in sprouting angiogenesis; IMP:BHF-UCL.
DR   GO; GO:0021836; P:chemorepulsion involved in postnatal olfactory bulb interneuron migration; IDA:UniProtKB.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IDA:UniProtKB.
DR   GO; GO:0060763; P:mammary duct terminal end bud growth; IEA:Ensembl.
DR   GO; GO:0070100; P:negative regulation of chemokine-mediated signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0033600; P:negative regulation of mammary gland epithelial cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0050925; P:negative regulation of negative chemotaxis; IDA:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0050772; P:positive regulation of axonogenesis; IDA:UniProtKB.
DR   GO; GO:0035385; P:Roundabout signaling pathway; IMP:BHF-UCL.
DR   Gene3D; 2.60.40.10; -; 9.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF00041; fn3; 3.
DR   Pfam; PF07679; I-set; 5.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00408; IGc2; 4.
DR   SMART; SM00406; IGv; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 5.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chemotaxis; Complete proteome;
KW   Developmental protein; Differentiation; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Membrane; Neurogenesis; Phosphoprotein;
KW   Polymorphism; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26   1651       Roundabout homolog 1.
FT                                /FTId=PRO_0000031033.
FT   TOPO_DOM     26    897       Extracellular. {ECO:0000255}.
FT   TRANSMEM    898    918       Helical. {ECO:0000255}.
FT   TOPO_DOM    919   1651       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       68    164       Ig-like C2-type 1.
FT   DOMAIN      170    257       Ig-like C2-type 2.
FT   DOMAIN      262    346       Ig-like C2-type 3.
FT   DOMAIN      351    446       Ig-like C2-type 4.
FT   DOMAIN      455    541       Ig-like C2-type 5.
FT   DOMAIN      563    657       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      676    773       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      778    874       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   MOD_RES     940    940       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:20068231}.
FT   MOD_RES    1038   1038       Phosphotyrosine; by ABL; in vitro.
FT                                {ECO:0000269|PubMed:10892742}.
FT   MOD_RES    1055   1055       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648}.
FT   MOD_RES    1073   1073       Phosphotyrosine; by ABL; in vitro.
FT                                {ECO:0000269|PubMed:10892742}.
FT   MOD_RES    1114   1114       Phosphotyrosine; by ABL; in vitro.
FT                                {ECO:0000269|PubMed:10892742}.
FT   MOD_RES    1240   1240       Phosphothreonine.
FT                                {ECO:0000269|PubMed:18669648}.
FT   MOD_RES    1297   1297       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648}.
FT   CARBOHYD    160    160       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    463    463       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    790    790       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    820    820       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    827    827       N-linked (GlcNAc...). {ECO:0000255}.
FT   DISULFID     89    147       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:17848514}.
FT   DISULFID    191    240       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    283    330       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    372    428       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    476    525       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VAR_SEQ       1     57       MKWKHVPFLVMISLLSLSPNHLFLAQLIPDPEDVERGNDHG
FT                                TPIPTSDNDDNSLGYT -> MIAEPAHFYLFGLICLCS
FT                                (in isoform 5 and isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043881.
FT   VAR_SEQ       1     39       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_010643.
FT   VAR_SEQ      40     57       HGTPIPTSDNDDNSLGYT -> MIAEPAHFYLFGLICLCS
FT                                (in isoform 3 and isoform 4).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_010644.
FT   VAR_SEQ     348    348       Q -> QVGS (in isoform 3, isoform 5 and
FT                                isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_010645.
FT   VAR_SEQ     543    543       Q -> QGKVN (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_010646.
FT   VAR_SEQ     938    946       Missing (in isoform 5 and isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043882.
FT   VAR_SEQ    1013   1067       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046084.
FT   VARIANT     336    336       V -> A (in dbSNP:rs9647397).
FT                                /FTId=VAR_053640.
FT   VARIANT    1055   1055       S -> N (in a breast cancer sample).
FT                                {ECO:0000269|PubMed:12082532}.
FT                                /FTId=VAR_019071.
FT   VARIANT    1091   1091       S -> N (in dbSNP:rs35456279).
FT                                /FTId=VAR_053641.
FT   VARIANT    1533   1533       E -> D (in a breast cancer sample;
FT                                dbSNP:rs36055689).
FT                                {ECO:0000269|PubMed:12082532}.
FT                                /FTId=VAR_019072.
FT   CONFLICT    182    182       A -> V (in Ref. 4; AAI15023).
FT                                {ECO:0000305}.
FT   CONFLICT    835    835       F -> L (in Ref. 4; AAI15023).
FT                                {ECO:0000305}.
FT   CONFLICT   1095   1095       G -> S (in Ref. 5; CAD98093).
FT                                {ECO:0000305}.
FT   CONFLICT   1223   1223       M -> T (in Ref. 2; Z95705).
FT                                {ECO:0000305}.
FT   CONFLICT   1443   1443       P -> L (in Ref. 5; CAD98093).
FT                                {ECO:0000305}.
FT   CONFLICT   1536   1536       D -> G (in Ref. 2; Z95705).
FT                                {ECO:0000305}.
FT   STRAND       66     72       {ECO:0000244|PDB:2V9T}.
FT   STRAND       77     79       {ECO:0000244|PDB:2V9T}.
FT   STRAND       85     87       {ECO:0000244|PDB:2V9T}.
FT   STRAND       90     95       {ECO:0000244|PDB:2V9T}.
FT   STRAND       98    103       {ECO:0000244|PDB:2V9T}.
FT   TURN        111    113       {ECO:0000244|PDB:2V9T}.
FT   STRAND      118    121       {ECO:0000244|PDB:2V9T}.
FT   STRAND      127    131       {ECO:0000244|PDB:2V9T}.
FT   STRAND      143    151       {ECO:0000244|PDB:2V9T}.
FT   STRAND      154    157       {ECO:0000244|PDB:2V9T}.
FT   STRAND      161    165       {ECO:0000244|PDB:2V9T}.
FT   STRAND      179    182       {ECO:0000244|PDB:2V9R}.
FT   STRAND      187    190       {ECO:0000244|PDB:2V9R}.
FT   STRAND      196    198       {ECO:0000244|PDB:2V9R}.
FT   STRAND      201    206       {ECO:0000244|PDB:2V9R}.
FT   STRAND      209    211       {ECO:0000244|PDB:2V9R}.
FT   STRAND      213    215       {ECO:0000244|PDB:2V9Q}.
FT   STRAND      218    221       {ECO:0000244|PDB:2V9R}.
FT   STRAND      224    229       {ECO:0000244|PDB:2V9R}.
FT   HELIX       232    234       {ECO:0000244|PDB:2V9R}.
FT   STRAND      236    244       {ECO:0000244|PDB:2V9R}.
FT   STRAND      247    250       {ECO:0000244|PDB:2V9R}.
FT   STRAND      254    259       {ECO:0000244|PDB:2V9R}.
FT   HELIX       261    266       {ECO:0000244|PDB:2V9Q}.
FT   STRAND      464    467       {ECO:0000244|PDB:2EO9}.
FT   STRAND      471    475       {ECO:0000244|PDB:2EO9}.
FT   STRAND      485    494       {ECO:0000244|PDB:2EO9}.
FT   STRAND      502    506       {ECO:0000244|PDB:2EO9}.
FT   STRAND      509    514       {ECO:0000244|PDB:2EO9}.
FT   HELIX       517    519       {ECO:0000244|PDB:2EO9}.
FT   STRAND      523    528       {ECO:0000244|PDB:2EO9}.
FT   STRAND      533    537       {ECO:0000244|PDB:2EO9}.
FT   STRAND      540    543       {ECO:0000244|PDB:2EO9}.
FT   HELIX       666    675       {ECO:0000244|PDB:4HLJ}.
FT   STRAND      676    680       {ECO:0000244|PDB:4HLJ}.
FT   STRAND      687    689       {ECO:0000244|PDB:4HLJ}.
FT   STRAND      691    699       {ECO:0000244|PDB:4HLJ}.
FT   STRAND      706    715       {ECO:0000244|PDB:4HLJ}.
FT   HELIX       719    721       {ECO:0000244|PDB:4HLJ}.
FT   STRAND      724    728       {ECO:0000244|PDB:4HLJ}.
FT   STRAND      735    738       {ECO:0000244|PDB:4HLJ}.
FT   STRAND      746    755       {ECO:0000244|PDB:4HLJ}.
FT   STRAND      766    769       {ECO:0000244|PDB:4HLJ}.
FT   STRAND      780    786       {ECO:0000244|PDB:3WIH}.
FT   STRAND      789    791       {ECO:0000244|PDB:3WIH}.
FT   STRAND      794    799       {ECO:0000244|PDB:3WIH}.
FT   HELIX       803    805       {ECO:0000244|PDB:4HLJ}.
FT   STRAND      812    818       {ECO:0000244|PDB:3WIH}.
FT   HELIX       822    824       {ECO:0000244|PDB:3WIH}.
FT   STRAND      826    831       {ECO:0000244|PDB:3WIH}.
FT   STRAND      836    839       {ECO:0000244|PDB:3WIH}.
FT   STRAND      848    854       {ECO:0000244|PDB:3WIH}.
FT   STRAND      867    869       {ECO:0000244|PDB:3WIH}.
FT   HELIX       880    883       {ECO:0000244|PDB:4HLJ}.
SQ   SEQUENCE   1651 AA;  180930 MW;  9D98CD7CAB73074D CRC64;
     MKWKHVPFLV MISLLSLSPN HLFLAQLIPD PEDVERGNDH GTPIPTSDND DNSLGYTGSR
     LRQEDFPPRI VEHPSDLIVS KGEPATLNCK AEGRPTPTIE WYKGGERVET DKDDPRSHRM
     LLPSGSLFFL RIVHGRKSRP DEGVYVCVAR NYLGEAVSHN ASLEVAILRD DFRQNPSDVM
     VAVGEPAVME CQPPRGHPEP TISWKKDGSP LDDKDERITI RGGKLMITYT RKSDAGKYVC
     VGTNMVGERE SEVAELTVLE RPSFVKRPSN LAVTVDDSAE FKCEARGDPV PTVRWRKDDG
     ELPKSRYEIR DDHTLKIRKV TAGDMGSYTC VAENMVGKAE ASATLTVQEP PHFVVKPRDQ
     VVALGRTVTF QCEATGNPQP AIFWRREGSQ NLLFSYQPPQ SSSRFSVSQT GDLTITNVQR
     SDVGYYICQT LNVAGSIITK AYLEVTDVIA DRPPPVIRQG PVNQTVAVDG TFVLSCVATG
     SPVPTILWRK DGVLVSTQDS RIKQLENGVL QIRYAKLGDT GRYTCIASTP SGEATWSAYI
     EVQEFGVPVQ PPRPTDPNLI PSAPSKPEVT DVSRNTVTLS WQPNLNSGAT PTSYIIEAFS
     HASGSSWQTV AENVKTETSA IKGLKPNAIY LFLVRAANAY GISDPSQISD PVKTQDVLPT
     SQGVDHKQVQ RELGNAVLHL HNPTVLSSSS IEVHWTVDQQ SQYIQGYKIL YRPSGANHGE
     SDWLVFEVRT PAKNSVVIPD LRKGVNYEIK ARPFFNEFQG ADSEIKFAKT LEEAPSAPPQ
     GVTVSKNDGN GTAILVSWQP PPEDTQNGMV QEYKVWCLGN ETRYHINKTV DGSTFSVVIP
     FLVPGIRYSV EVAASTGAGS GVKSEPQFIQ LDAHGNPVSP EDQVSLAQQI SDVVKQPAFI
     AGIGAACWII LMVFSIWLYR HRKKRNGLTS TYAGIRKVPS FTFTPTVTYQ RGGEAVSSGG
     RPGLLNISEP AAQPWLADTW PNTGNNHNDC SISCCTAGNG NSDSNLTTYS RPADCIANYN
     NQLDNKQTNL MLPESTVYGD VDLSNKINEM KTFNSPNLKD GRFVNPSGQP TPYATTQLIQ
     SNLSNNMNNG SGDSGEKHWK PLGQQKQEVA PVQYNIVEQN KLNKDYRAND TVPPTIPYNQ
     SYDQNTGGSY NSSDRGSSTS GSQGHKKGAR TPKVPKQGGM NWADLLPPPP AHPPPHSNSE
     EYNISVDESY DQEMPCPVPP ARMYLQQDEL EEEEDERGPT PPVRGAASSP AAVSYSHQST
     ATLTPSPQEE LQPMLQDCPE ETGHMQHQPD RRRQPVSPPP PPRPISPPHT YGYISGPLVS
     DMDTDAPEEE EDEADMEVAK MQTRRLLLRG LEQTPASSVG DLESSVTGSM INGWGSASEE
     DNISSGRSSV SSSDGSFFTD ADFAQAVAAA AEYAGLKVAR RQMQDAAGRR HFHASQCPRP
     TSPVSTDSNM SAAVMQKTRP AKKLKHQPGH LRRETYTDDL PPPPVPPPAI KSPTAQSKTQ
     LEVRPVVVPK LPSMDARTDR SSDRKGSSYK GREVLDGRQV VDMRTNPGDP REAQEQQNDG
     KGRGNKAAKR DLPPAKTHLI QEDILPYCRP TFPTSNNPRD PSSSSSMSSR GSGSRQREQA
     NVGRRNIAEM QVLGGYERGE DNNEELEETE S
//
